Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Therapeutic Innovation & Regulatory Science
|
May 2, 2018
Sources of Safety Data and Statistical Strategies for Design and Analysis: Clinical Trials
Richard C Zink, Olga Marchenko, Matilde Sanchez-Kam, et al.
Journal of Biopharmaceutical Statistics
|
September 15, 2015
Nine-year change in statistical design, profile, and success rates of Phase II oncology trials
Anastasia Ivanova, Barry Paul, Olga Marchenko, et al.
Therapeutic Innovation & Regulatory Science
|
May 8, 2015
Advances in Statistical Approaches Oncology Drug Development
Anastasia Ivanova, Gary L Rosner, Olga Marchenko, et al.
Journal of Biopharmaceutical Statistics
|
March 11, 2017
Comparing oncology clinical programs by use of innovative designs and expected net present value optimization: Which adaptive approach leads to the best result?
Tom Parke, Olga Marchenko, Vladimir Anisimov, et al.
Therapeutic Innovation & Regulatory Science
|
May 2, 2018
Sources of Safety Data and Statistical Strategies for Design and Analysis: Real World Insights
Olga Marchenko, Estelle Russek-Cohen, Mark Levenson, et al.
International Journal of Surgery Case Reports
|
September 15, 2024
A rare case of endoscopic removal of the metal fragment from the segmental bronchus after gunshot injury to the chest in combat patient injured in the war in Ukraine
Igor Lurin, Eduard Khoroshun, Vitalii Makarov, et al.
Therapeutic Innovation & Regulatory Science
|
May 3, 2022
Statistical and Operational Considerations for 2-Stage Adaptive Designs with Simultaneous Evaluation of Overall and Marker-Selected Populations in Oncology Confirmatory Trials
Weidong Zhang, Sunhee Ro, Qi Jiang, et al.
Therapeutic Innovation & Regulatory Science
|
May 13, 2023
Statistical Considerations on the Use of RWD/RWE for Oncology Drug Approvals: Overview and Lessons Learned
Sunhee K Ro, Weidong Zhang, Qi Jiang, et al.
Statistics in Biopharmaceutical Research
|
June 5, 2023
Accuracy and Safety of Novel Designs for Phase I Drug-Combination Oncology Trials
Rong Liu, Ying Yuan, Suman Sen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2023
Tumor-Agnostic Approvals: Insights and Practical Considerations
Chengxing Cindy Lu, Robert A Beckman, Xiaoyun Nicole Li, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Therapeutic Innovation & Regulatory Science
|
May 2, 2018
Sources of Safety Data and Statistical Strategies for Design and Analysis: Clinical Trials
Richard C Zink, Olga Marchenko, Matilde Sanchez-Kam, et al.
Journal of Biopharmaceutical Statistics
|
September 15, 2015
Nine-year change in statistical design, profile, and success rates of Phase II oncology trials
Anastasia Ivanova, Barry Paul, Olga Marchenko, et al.
Therapeutic Innovation & Regulatory Science
|
May 8, 2015
Advances in Statistical Approaches Oncology Drug Development
Anastasia Ivanova, Gary L Rosner, Olga Marchenko, et al.
Journal of Biopharmaceutical Statistics
|
March 11, 2017
Comparing oncology clinical programs by use of innovative designs and expected net present value optimization: Which adaptive approach leads to the best result?
Tom Parke, Olga Marchenko, Vladimir Anisimov, et al.
Therapeutic Innovation & Regulatory Science
|
May 2, 2018
Sources of Safety Data and Statistical Strategies for Design and Analysis: Real World Insights
Olga Marchenko, Estelle Russek-Cohen, Mark Levenson, et al.
International Journal of Surgery Case Reports
|
September 15, 2024
A rare case of endoscopic removal of the metal fragment from the segmental bronchus after gunshot injury to the chest in combat patient injured in the war in Ukraine
Igor Lurin, Eduard Khoroshun, Vitalii Makarov, et al.
Therapeutic Innovation & Regulatory Science
|
May 3, 2022
Statistical and Operational Considerations for 2-Stage Adaptive Designs with Simultaneous Evaluation of Overall and Marker-Selected Populations in Oncology Confirmatory Trials
Weidong Zhang, Sunhee Ro, Qi Jiang, et al.
Therapeutic Innovation & Regulatory Science
|
May 13, 2023
Statistical Considerations on the Use of RWD/RWE for Oncology Drug Approvals: Overview and Lessons Learned
Sunhee K Ro, Weidong Zhang, Qi Jiang, et al.
Statistics in Biopharmaceutical Research
|
June 5, 2023
Accuracy and Safety of Novel Designs for Phase I Drug-Combination Oncology Trials
Rong Liu, Ying Yuan, Suman Sen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2023
Tumor-Agnostic Approvals: Insights and Practical Considerations
Chengxing Cindy Lu, Robert A Beckman, Xiaoyun Nicole Li, et al.
Page
of 3